We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$118B
AUM Growth
+$2.37B
Cap. Flow
-$2.87B
Cap. Flow %
-2.42%
Top 10 Hldgs %
14.37%
Holding
3,058
New
95
Increased
1,049
Reduced
1,331
Closed
82

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$274M
2
MSFT icon
Microsoft
MSFT
+$263M
3
CMCSA icon
Comcast
CMCSA
+$248M
4
APH icon
Amphenol
APH
+$238M
5
ELV icon
Elevance Health
ELV
+$238M

Sector Composition

Rank Sector Weight
1 Technology 15.59%
2 Financials 14.66%
3 Healthcare 14.25%
4 Consumer Discretionary 10.15%
5 Industrials 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEL icon
2451
Genesis Energy
GEL
$1.84B
$599K ﹤0.01%
15,779
+305
+2% +$11.2K
IPAR icon
2452
Interparfums
IPAR
$3.92B
$599K ﹤0.01%
18,567
BEAT
2453
DELISTED
BioTelemetry, Inc.
BEAT
$598K ﹤0.01%
32,200
+10,500
+48% +$198K
RYAM icon
2454
Rayonier Advanced Materials
RYAM
$565M
$596K ﹤0.01%
44,600
XENT
2455
DELISTED
Intersect ENT, Inc
XENT
$596K ﹤0.01%
37,620
TARO
2456
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$595K ﹤0.01%
5,385
+195
+4% +$25.8K
GIL icon
2457
Gildan
GIL
$9.25B
$593K ﹤0.01%
21,230
-350
-2% -$10.3K
ARAY icon
2458
Accuray
ARAY
$28.4M
$592K ﹤0.01%
92,991
ARCB icon
2459
ArcBest
ARCB
$3.44B
$592K ﹤0.01%
31,140
-1,317
-4% -$23.8K
TSLA icon
2460
PUT
Tesla
TSLA
$1.24T
$592K ﹤0.01%
43,500
+25,500
+142% +$368K
WRLD icon
2461
World Acceptance Corp
WRLD
$950M
$584K ﹤0.01%
11,918
+1,500
+14% +$71.9K
CENX icon
2462
Century Aluminum
CENX
$4.57B
$580K ﹤0.01%
83,500
SN
2463
DELISTED
Sanchez Energy Corporation
SN
$579K ﹤0.01%
65,490
+2,600
+4% +$20K
ADXS
2464
DELISTED
Advaxis Inc
ADXS
$578K ﹤0.01%
3,607
OSPN icon
2465
OneSpan
OSPN
$562M
$577K ﹤0.01%
32,752
LUMO
2466
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$577K ﹤0.01%
4,267
-200
-4% -$19.9K
AVXS
2467
DELISTED
AveXis, Inc. Common Stock
AVXS
$577K ﹤0.01%
14,000
CMCM
2468
Cheetah Mobile
CMCM
$88.8M
$576K ﹤0.01%
9,250
ANH
2469
DELISTED
Anworth Mortgage Asset Corporation
ANH
$576K ﹤0.01%
117,003
-112,030
-49% -$549K
PRO
2470
DELISTED
PROS Holdings
PRO
$573K ﹤0.01%
25,350
-3,660
-13% -$70.2K
FRO icon
2471
Frontline
FRO
$8.75B
$571K ﹤0.01%
79,600
SHOR
2472
DELISTED
ShoreTel, Inc.
SHOR
$571K ﹤0.01%
71,410
SGRY icon
2473
Surgery Partners
SGRY
$2.06B
$569K ﹤0.01%
28,100
+1,100
+4% +$20.2K
LL
2474
DELISTED
LL Flooring Holdings, Inc.
LL
$569K ﹤0.01%
28,916
GSK icon
2475
GSK
GSK
$103B
$566K ﹤0.01%
10,491
-4,512
-30% -$247K

Similar funds

AllianceBernstein's Q3 2016 Portfolio in Review

As of Q3 2016, AllianceBernstein held 3,058 positions worth $118B, up 2% from $116B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

AllianceBernstein's Q3 2016 filing shows 95 new, 1,049 increased, 1,331 reduced and 82 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,294,681 shares worth $106M. The largest sale was Pfizer, an estimated $274M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • AllianceBernstein's largest Q3 2016 buy was Teva Pharmaceuticals: 2,294,681 shares worth $106M.
  • AllianceBernstein added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $567M increase.
  • AllianceBernstein's biggest Q3 2016 reduction was Pfizer, cutting an estimated $274M.
  • AllianceBernstein fully exited EMC CORPORATION in Q3 2016, selling an estimated $99.6M.
  • AllianceBernstein's ten largest holdings make up 14% of its $118B portfolio in Q3 2016.
  • AllianceBernstein opened 95 new positions and closed 82 in Q3 2016.
  • AllianceBernstein's portfolio value rose 2% quarter-over-quarter to $118B.

Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.